
### [NCIT:C7619](http://purl.obolibrary.org/obo/NCIT_C7619)
**Label:** Recurrent Carcinoma

**Subclasses:** [NCIT:C7902](http://purl.obolibrary.org/obo/NCIT_C7902) (Recurrent Prostate Carcinoma), [NCIT:C7825](http://purl.obolibrary.org/obo/NCIT_C7825) (Recurrent Renal Cell Carcinoma), [NCIT:C6417](http://purl.obolibrary.org/obo/NCIT_C6417) (Recurrent Adrenal Cortex Carcinoma), [NCIT:C7626](http://purl.obolibrary.org/obo/NCIT_C7626) (Recurrent Pancreatic Carcinoma), [NCIT:C7508](http://purl.obolibrary.org/obo/NCIT_C7508) (Recurrent Urethra Carcinoma), [NCIT:C7903](http://purl.obolibrary.org/obo/NCIT_C7903) (Recurrent Skin Carcinoma), [NCIT:C7623](http://purl.obolibrary.org/obo/NCIT_C7623) (Recurrent Urinary Tract Carcinoma), [NCIT:C8757](http://purl.obolibrary.org/obo/NCIT_C8757) (Recurrent Lung Adenocarcinoma), [NCIT:C7622](http://purl.obolibrary.org/obo/NCIT_C7622) (Recurrent Digestive System Carcinoma), [NCIT:C8953](http://purl.obolibrary.org/obo/NCIT_C8953) (Recurrent Lung Carcinoma), [NCIT:C4995](http://purl.obolibrary.org/obo/NCIT_C4995) (Recurrent Bladder Adenocarcinoma), [NCIT:C8634](http://purl.obolibrary.org/obo/NCIT_C8634) (Recurrent Rectosigmoid Carcinoma), [NCIT:C115433](http://purl.obolibrary.org/obo/NCIT_C115433) (Recurrent Pancreatic Neuroendocrine Carcinoma), [NCIT:C7624](http://purl.obolibrary.org/obo/NCIT_C7624) (Recurrent Head and Neck Carcinoma), [NCIT:C8753](http://purl.obolibrary.org/obo/NCIT_C8753) (Recurrent Large Cell Lung Carcinoma), [NCIT:C8236](http://purl.obolibrary.org/obo/NCIT_C8236) (Recurrent Hypopharyngeal Squamous Cell Carcinoma), [NCIT:C7860](http://purl.obolibrary.org/obo/NCIT_C7860) (Recurrent Vaginal Carcinoma), [NCIT:C7783](http://purl.obolibrary.org/obo/NCIT_C7783) (Recurrent Non-Small Cell Lung Carcinoma), [NCIT:C8633](http://purl.obolibrary.org/obo/NCIT_C8633) (Recurrent Esophageal Squamous Cell Carcinoma), [NCIT:C4034](http://purl.obolibrary.org/obo/NCIT_C4034) (Recurrent Laryngeal Carcinoma), [NCIT:C7621](http://purl.obolibrary.org/obo/NCIT_C7621) (Recurrent Male Reproductive System Carcinoma), [NCIT:C136650](http://purl.obolibrary.org/obo/NCIT_C136650) (Recurrent Cervical Adenosquamous Carcinoma), [NCIT:C136651](http://purl.obolibrary.org/obo/NCIT_C136651) (Recurrent Cervical Adenocarcinoma), [NCIT:C8037](http://purl.obolibrary.org/obo/NCIT_C8037) (Recurrent Lip and Oral Cavity Carcinoma), [NCIT:C7620](http://purl.obolibrary.org/obo/NCIT_C7620) (Recurrent Female Reproductive System Carcinoma), [NCIT:C9046](http://purl.obolibrary.org/obo/NCIT_C9046) (Recurrent Childhood Hepatocellular Carcinoma), [NCIT:C132294](http://purl.obolibrary.org/obo/NCIT_C132294) (Recurrent Endometrial Serous Adenocarcinoma), [NCIT:C8230](http://purl.obolibrary.org/obo/NCIT_C8230) (Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma), [NCIT:C8231](http://purl.obolibrary.org/obo/NCIT_C8231) (Recurrent Nasopharyngeal Undifferentiated Carcinoma), [NCIT:C6060](http://purl.obolibrary.org/obo/NCIT_C6060) (Recurrent Oral Cavity Squamous Cell Carcinoma), [NCIT:C9054](http://purl.obolibrary.org/obo/NCIT_C9054) (Recurrent Vulvar Carcinoma), [NCIT:C133709](http://purl.obolibrary.org/obo/NCIT_C133709) (Recurrent Head and Neck Squamous Cell Carcinoma), [NCIT:C7828](http://purl.obolibrary.org/obo/NCIT_C7828) (Recurrent Parathyroid Gland Carcinoma), [NCIT:C7908](http://purl.obolibrary.org/obo/NCIT_C7908) (Recurrent Thyroid Gland Carcinoma), [NCIT:C8607](http://purl.obolibrary.org/obo/NCIT_C8607) (Recurrent Inflammatory Breast Carcinoma), [NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma), [NCIT:C3998](http://purl.obolibrary.org/obo/NCIT_C3998) (Recurrent Colon Carcinoma), [NCIT:C3999](http://purl.obolibrary.org/obo/NCIT_C3999) (Recurrent Esophageal Carcinoma), [NCIT:C7833](http://purl.obolibrary.org/obo/NCIT_C7833) (Recurrent Ovarian Carcinoma), [NCIT:C115443](http://purl.obolibrary.org/obo/NCIT_C115443) (Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma), [NCIT:C115442](http://purl.obolibrary.org/obo/NCIT_C115442) (Recurrent Lip and Oral Cavity Squamous Cell Carcinoma), [NCIT:C8245](http://purl.obolibrary.org/obo/NCIT_C8245) (Recurrent Laryngeal Squamous Cell Carcinoma), [NCIT:C115441](http://purl.obolibrary.org/obo/NCIT_C115441) (Recurrent Primary Peritoneal Carcinoma), [NCIT:C115440](http://purl.obolibrary.org/obo/NCIT_C115440) (Recurrent Merkel Cell Carcinoma), [NCIT:C5014](http://purl.obolibrary.org/obo/NCIT_C5014) (Recurrent Squamous Cell Lung Carcinoma), [NCIT:C9255](http://purl.obolibrary.org/obo/NCIT_C9255) (Recurrent Ureter Carcinoma), [NCIT:C27325](http://purl.obolibrary.org/obo/NCIT_C27325) (Recurrent Cholangiocarcinoma), [NCIT:C7870](http://purl.obolibrary.org/obo/NCIT_C7870) (Recurrent Penile Carcinoma), [NCIT:C7793](http://purl.obolibrary.org/obo/NCIT_C7793) (Recurrent Anal Canal Carcinoma), [NCIT:C7110](http://purl.obolibrary.org/obo/NCIT_C7110) (Recurrent Liver Carcinoma), [NCIT:C67558](http://purl.obolibrary.org/obo/NCIT_C67558) (Recurrent Nasal Cavity and Paranasal Sinus Carcinoma), [NCIT:C115093](http://purl.obolibrary.org/obo/NCIT_C115093) (Recurrent Oropharyngeal Undifferentiated Carcinoma), [NCIT:C8051](http://purl.obolibrary.org/obo/NCIT_C8051) (Recurrent Oropharyngeal Carcinoma), [NCIT:C136649](http://purl.obolibrary.org/obo/NCIT_C136649) (Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified), [NCIT:C7926](http://purl.obolibrary.org/obo/NCIT_C7926) (Recurrent Salivary Gland Carcinoma), [NCIT:C7804](http://purl.obolibrary.org/obo/NCIT_C7804) (Recurrent Cervical Carcinoma), [NCIT:C5103](http://purl.obolibrary.org/obo/NCIT_C5103) (Recurrent Pharyngeal Carcinoma), [NCIT:C8216](http://purl.obolibrary.org/obo/NCIT_C8216) (Recurrent Oral Cavity Adenoid Cystic Carcinoma), [NCIT:C8214](http://purl.obolibrary.org/obo/NCIT_C8214) (Recurrent Oral Cavity Verrucous Carcinoma), [NCIT:C8215](http://purl.obolibrary.org/obo/NCIT_C8215) (Recurrent Oral Cavity Mucoepidermoid Carcinoma), [NCIT:C8213](http://purl.obolibrary.org/obo/NCIT_C8213) (Recurrent Lip Basal Cell Carcinoma), [NCIT:C8254](http://purl.obolibrary.org/obo/NCIT_C8254) (Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C9264](http://purl.obolibrary.org/obo/NCIT_C9264) (Recurrent Hepatocellular Carcinoma), [NCIT:C6076](http://purl.obolibrary.org/obo/NCIT_C6076) (Recurrent Oral Cavity Carcinoma), [NCIT:C7880](http://purl.obolibrary.org/obo/NCIT_C7880) (Recurrent Adult Liver Carcinoma), [NCIT:C128807](http://purl.obolibrary.org/obo/NCIT_C128807) (Recurrent Intrahepatic Cholangiocarcinoma), [NCIT:C9067](http://purl.obolibrary.org/obo/NCIT_C9067) (Recurrent Adult Hepatocellular Carcinoma), [NCIT:C126307](http://purl.obolibrary.org/obo/NCIT_C126307) (Recurrent Bladder Urothelial Carcinoma), [NCIT:C9072](http://purl.obolibrary.org/obo/NCIT_C9072) (Recurrent Uterine Corpus Carcinoma), [NCIT:C115429](http://purl.obolibrary.org/obo/NCIT_C115429) (Recurrent Fallopian Tube Carcinoma), [NCIT:C8627](http://purl.obolibrary.org/obo/NCIT_C8627) (Recurrent Esophageal Adenocarcinoma), [NCIT:C8902](http://purl.obolibrary.org/obo/NCIT_C8902) (Recurrent Bladder Squamous Cell Carcinoma), [NCIT:C8625](http://purl.obolibrary.org/obo/NCIT_C8625) (Recurrent Colorectal Carcinoma), [NCIT:C8747](http://purl.obolibrary.org/obo/NCIT_C8747) (Recurrent Adenosquamous Lung Carcinoma), [NCIT:C7899](http://purl.obolibrary.org/obo/NCIT_C7899) (Recurrent Bladder Carcinoma), [NCIT:C9237](http://purl.obolibrary.org/obo/NCIT_C9237) (Recurrent Gastric Carcinoma), [NCIT:C7894](http://purl.obolibrary.org/obo/NCIT_C7894) (Recurrent Small Intestinal Carcinoma), [NCIT:C7893](http://purl.obolibrary.org/obo/NCIT_C7893) (Recurrent Extrahepatic Bile Duct Carcinoma), [NCIT:C9238](http://purl.obolibrary.org/obo/NCIT_C9238) (Recurrent Rectal Carcinoma), [NCIT:C8221](http://purl.obolibrary.org/obo/NCIT_C8221) (Recurrent Oropharyngeal Squamous Cell Carcinoma), [NCIT:C9352](http://purl.obolibrary.org/obo/NCIT_C9352) (Recurrent Duodenal Carcinoma), [NCIT:C7771](http://purl.obolibrary.org/obo/NCIT_C7771) (Recurrent Breast Carcinoma), [NCIT:C9240](http://purl.obolibrary.org/obo/NCIT_C9240) (Recurrent Nasopharynx Carcinoma), [NCIT:C9241](http://purl.obolibrary.org/obo/NCIT_C9241) (Recurrent Hypopharyngeal Carcinoma), [NCIT:C131218](http://purl.obolibrary.org/obo/NCIT_C131218) (Recurrent Urethral Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.40%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40141](http://purl.obolibrary.org/obo/NCIT_C40141) (Wolffian Adnexal Tumor))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40139](http://purl.obolibrary.org/obo/NCIT_C40139) (Uterine Ligament Clear Cell Adenocarcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 40.91%


